2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Pharmos: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout levotofisopam - Hyperuricemia, Gout | Phase 2 | Unknown | Pharmos | 20 | 2012-01-01 | 2012-01-27 |
| Proof-of Concept Study of Topical 3%-Diclofenac-Nano-Emulsion Cream for Knee OA Pain 3%-Diclofenac-Nano-Emulsion Cream, Placebo cream - Osteoarthritis of the Knee | Phase 2 | Completed | Pharmos | 123 | 2007-06-01 | 2011-08-02 |
| A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome Dextofisopam - Irritable Bowel Syndrome | Phase 2 | Completed | Pharmos | 324 | 2007-06-01 | 2011-08-02 |
Gout (1) · Hyperuricemia (1) · Irritable Bowel Syndrome (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1)
tofisopam (2)
United States (2) · Israel (1)
Eisenberg Elon, MD (1) · John S. Sundy, MD, PhD (1) · S Colin Neill (1)